Estradiol valerate and dienogest:A new approach to oral contraception

International Journal of Women's Health

Volumn 3, Issue 1, 2011, Pages 281-286

  Kiley, Jessica W ^a   Shulman, Lee P ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Combination; Dienogest; Estradiol valerate; Oral contraception

Indexed keywords

DIENOGEST; DIENOGEST PLUS ESTRADIOL VALERATE; ESTRADIOL VALERATE; ETHINYLESTRADIOL; GESTAGEN; LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT; PLACEBO;

ACNE; ANTIANDROGEN THERAPY; BREAKTHROUGH BLEEDING; DEEP VEIN THROMBOSIS; DIARRHEA; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEADACHE; HEART INFARCTION; HUMAN; LIVER HYPERPLASIA; MASTALGIA; MENSTRUATION; MENSTRUATION DISORDER; METABOLIC DISORDER; METABOLIC SYNDROME X; METRORRHAGIA; NODULAR HYPERPLASIA; OCULAR HISTOPLASMOSIS; ORAL CONTRACEPTION; PATIENT SATISFACTION; REVIEW; RHINOPHARYNGITIS; SIDE EFFECT; UTERUS MYOMA; WEIGHT GAIN;

EID: 84055216915     PISSN: None     EISSN: 11791411     Source Type: Journal    
DOI: 10.2147/ijwh.s22645     Document Type: Review

References (21)

1. Mosher WD, Jones J. Use of contraception in the United States: 1982-2008. Vital Health Stat 23. 2010;29:1-44.
2. Jensen JT. Evaluation of a new estradiol oral contraceptive: Estradiol valerate and dienogest. Expert Opin Pharmacother. 2010;11(7): 1147-1157.
3. Palacios S, Wildt L, Parke S, Machlitt A, Romer T, Bitzer J. Effcacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate/dienogest): A Phase III trial. Eur J Obstet Gynecol Reprod Biol. 2010;149(1):57-62.
4. Natazia - a new oral contraceptive. Med Lett Drugs Ther. 2010;52(1346): 71-72.
5. Hoy SM, Scott LJ. Estradiol valerate/dienogest:In oral contraception. Drugs. 2009;69(12):1635-1646.
6. Trussell J. Contraceptive failure in the United States. Contraception. 2004;70(2):89-96.
7. Speroff L, Darney PD. Oral contraception. In: Speroff L, Darney PD, editors. A Clinical Guide for Contraception. Philadelphia, PA: Lippincott Williams and Wilkins; 2011.
8. Kiley J, Hammond C. Combined oral contraceptives: A comprehensive review. Clin Obstet Gynecol. 2007;50(4):868-877.
9. World Health Organization Task Force on Oral Contraception. A randomized, double-blind study of two combined oral contraceptives containing the same progestogen, but different estrogens. Contraception. 1980;21(5):445-459.
10. Astedt B, Jeppsson S, Liedholm P, Rannevik G, Svanberg L. Clinical trial of a new oral contraceptive pill containing the natural oestrogen 17 beta-oestradiol. Br J Obstet Gynaecol. 1979;86(9):732-736.
11. Csemiczky G, Dieben T, Coeling Bennink HJ, Landgren BM. The pharmacodynamic effects of an oral contraceptive containing 3 mg micronized 17 beta-estradiol and 0.150 mg desogestrel for 21 days, followed by 0.030 mg desogestrel only for 7 days. Contraception. 1996; 54(6):333-338.
12. Hirvonen E, Allonen H, Anttila M, et al. Oral contraceptive containing natural estradiol for premenopausal women. Maturitas. 1995;21(1): 27-32.
13. Serup J, Bostofte E, Larsen S, Westergaard J, Lebech PE. Natural oestrogens for oral contraception. Lancet. 1979;2(8140):471-472.
14. Endrikat J, Parke S, Trummer D, Schmidt W, Duijkers I, Klipping C. Ovulation inhibition with four variations of a four-phasic estradiol valer-ate/dienogest combined oral contraceptive: Results of two prospective, randomized, open-label studies. Contraception. 2008;78(3):218-225.
15. Zeun S, Lu M, Uddin A, Zeiler B, Morrison D, Blode H. Pharmacokinet-ics of an oral contraceptive containing oestradiol valerate and dienogest. Eur J Contracept Reprod Health Care. 2009;14(3):221-232.
16. Parke S, Nahum G, Mellinger U, Junge W. Metabolic effect of a new four-phasic oral contraceptive containing estradiol valerate and dienogest. Obstet Gynecol. 2008;111 Suppl 4:S12-S13.
17. Parke S, Junge W, Mellinger U, Duijkers I, Klipping C. Comparative effects of a four-phasic regimen of estradiol valerate/dienogest versus ethinylestradiol/levonorgestrel on haemostatic parameters. Hum Reprod. 2008;23 Suppl 1:i78-i79.
18. Ahrendt HJ, Makalova D, Parke S, Mellinger U, Mansour D. Bleeding pattern and cycle control with an estradiol-based oral contraceptive: A seven-cycle, randomized comparative trial of estradiol valerate/ dienogest and ethinyl estradiol/levonorgestrel. Contraception. 2009; 80(5):436-444.
19. Moreau C, Cleland K, Trussell J. Contraceptive discontinuation attributed to method dissatisfaction in the United States. Contraception. 2007;76(4):267-272.
20. Burkman R, Schlesselman JJ, Zieman M. Safety concerns and health benefts associated with oral contraception. Am J Obstet Gynecol. 2004;190 Suppl 4:S5-S22.
21. Fraser I, Zeun S, Machlitt A, Mellinger U. A novel oral contraceptive comprising estradiol valerate/dienogest for the treatment of heavy and/ or prolonged menstrual bleeding without organic cause: A double-blind, randomised, placebo-controlled trial. Int J Gynecol Obstet. 2009; 107 Suppl 2:S183.